Joint Management Committee. 9 (a) Composition of the JMC........................................................................9 (b) JMC Meetings.................................................................................10 (c) JMC Responsibilities.........................................................................10 (d) Deadlock.....................................................................................10 2.6 SCHERING'S DEVELOPMENT OBLIGATIONS...........................................................10 (a) Schering Diligence...........................................................................10 (b) Opportunity to Cure..........................................................................11 (c) Research and Development Activities..........................................................11 (d) Licensed Product Registrations; Pricing Reimbursement Approvals..............................11 (e) Data.........................................................................................12 (f)
Appears in 3 contracts
Samples: Exclusive License Agreement (Atherogenics Inc), Exclusive License Agreement (Atherogenics Inc), Exclusive License Agreement (Atherogenics Inc)
Joint Management Committee. 9 (a) Composition of the JMC........................................................................9 (b) JMC Meetings.................................................................................10 ..................................................................................9 (c) JMC Responsibilities.........................................................................10 (d) Deadlock.....................................................................................10 2.6 SCHERINGSPL'S DEVELOPMENT OBLIGATIONS...........................................................................................................................10 (a) Schering SPL Diligence...........................................................................................................................................................10 (b) Opportunity to Cure..........................................................................11 10 (c) Research and Development Activities..........................................................11 (d) Licensed Product Registrations; Pricing Reimbursement Approvals..............................11 (e) Data.........................................................................................12 11 (f)
Appears in 3 contracts
Samples: Exclusive License Agreement (Atherogenics Inc), Exclusive License Agreement (Atherogenics Inc), Exclusive License Agreement (Atherogenics Inc)